[M3, promyelocytic leukemia].
Tsuruoka
N
N
Department of Hematology, Showa University School of Medicine.
D000970:Antineoplastic Agents / Q000627:therapeutic use; D019677:Artificial Gene Fusion; D002884:Chromosomes, Human, Pair 15; D002886:Chromosomes, Human, Pair 17; D006801:Humans; D015473:Leukemia, Promyelocytic, Acute / Q000188:drug therapy / Q000235:genetics; D011379:Prognosis; D018168:Receptors, Retinoic Acid / Q000235:genetics; D000072482:Retinoic Acid Receptor alpha; D014178:Translocation, Genetic; D014212:Tretinoin / Q000627:therapeutic use
D000970:Antineoplastic Agents; C000607071:RARA protein, human; D018168:Receptors, Retinoic Acid; D000072482:Retinoic Acid Receptor alpha; D014212:Tretinoin